AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Tirzepatide in South Africa
12 products registered with SAHPRA — 12 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MOUNJARO 2,5 mg | 57/21.13/0821 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| MOUNJARO 15 mg | 57/21.13/0826 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| PERSOVANCE 7,5 mg | 57/21.13/0829.823 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| MOUNJARO 5 mg | 57/21.13/0822 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| MOUNJARO 7,5 mg | 57/21.13/0823 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| MOUNJARO 10 mg | 57/21.13/0824 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| MOUNJARO 12,5 mg | 57/21.13/0825 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| PERSOVANCE 10 mg | 57/21.13/0830.824 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| PERSOVANCE 12,5 mg | 57/21.13/0831.825 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| PERSOVANCE 15 mg | 57/21.13/0823.826 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| PERSOVANCE 2,5 mg | 57/21.13/0827.821 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
| PERSOVANCE 5 mg | 57/21.13/0828.822 | Eli Lilly (S.A.) (Pty) Ltd | active | 9 Apr 2029 |
Tirzepatide — SAHPRA Registration Details
SAHPRA (South Africa) has 12 registered products containing Tirzepatide, of which 12 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Tirzepatide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.